CA2000548A1 - Conformable bandage and coating material - Google Patents

Conformable bandage and coating material

Info

Publication number
CA2000548A1
CA2000548A1 CA2000548A CA2000548A CA2000548A1 CA 2000548 A1 CA2000548 A1 CA 2000548A1 CA 2000548 A CA2000548 A CA 2000548A CA 2000548 A CA2000548 A CA 2000548A CA 2000548 A1 CA2000548 A1 CA 2000548A1
Authority
CA
Canada
Prior art keywords
coating material
conformable
conformable bandage
stinging
desiccation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2000548A
Other languages
French (fr)
Other versions
CA2000548C (en
Inventor
Ann B. Salamone
Joseph C. Salamone
Alfred P. Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rochal Industries Inc
Original Assignee
Ann B. Salamone
Joseph C. Salamone
Alfred P. Olson
Rochal Industries, Inc.
Rochal Industries, Inc. (Florida Corporation)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ann B. Salamone, Joseph C. Salamone, Alfred P. Olson, Rochal Industries, Inc., Rochal Industries, Inc. (Florida Corporation) filed Critical Ann B. Salamone
Publication of CA2000548A1 publication Critical patent/CA2000548A1/en
Application granted granted Critical
Publication of CA2000548C publication Critical patent/CA2000548C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A61F13/023—Adhesive plasters or dressings wound covering film layers without a fluid handling layer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/21—Silicone

Abstract

SS/sas 5696s ABSTRACT

Combinations of alkyl siloxy siloxane-containing polymers admixed with liquid polydimethylsiloxanes are excellent non-stinging, non-irritating liquid coating material for forming films which act as conformable bandages adhering to and protecting nails, skin and mucous membrane wounds from abrasion, contamination, and desiccation, while stopping pain from exposed nerve ends and allowing body fluid evaporation.
CA002000548A 1988-10-12 1989-10-12 Conformable bandage and coating material Expired - Lifetime CA2000548C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25665188A 1988-10-12 1988-10-12
US07/256,651 1988-10-12
US07/416,924 US4987893A (en) 1988-10-12 1989-10-04 Conformable bandage and coating material
US07/416,924 1989-10-04

Publications (2)

Publication Number Publication Date
CA2000548A1 true CA2000548A1 (en) 1990-04-12
CA2000548C CA2000548C (en) 2000-12-05

Family

ID=26945505

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002000548A Expired - Lifetime CA2000548C (en) 1988-10-12 1989-10-12 Conformable bandage and coating material

Country Status (8)

Country Link
US (1) US4987893A (en)
EP (1) EP0438496B1 (en)
JP (1) JP2918263B2 (en)
AU (1) AU620653B2 (en)
CA (1) CA2000548C (en)
DE (1) DE68923456T2 (en)
HK (1) HK1007690A1 (en)
WO (1) WO1990003809A1 (en)

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5103812A (en) * 1988-10-12 1992-04-14 Rochal Industries, Inc. Conformable bandage and coating material
US5246705A (en) * 1992-04-08 1993-09-21 Cygnus Therapeutic System Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
US5288827A (en) * 1993-02-17 1994-02-22 Ciba-Geigy Corporation Copolymer of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives
GB9411530D0 (en) * 1994-06-09 1994-08-03 Quayle Rachel A Use of polymers as film-forming barrier materials
CN1225230C (en) * 1995-06-07 2005-11-02 南方生物系统公司 High viscosity liquid controlled delivery system
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US6730380B2 (en) 1996-02-20 2004-05-04 Safeskin Corp. Readily-donned elastomeric articles
US5948400A (en) * 1997-11-20 1999-09-07 Smith & Nephew Inc. Method of applying a pressure-sensitive adhesive wound dressing and water-based skin treatment composition
AU1800099A (en) * 1997-11-25 1999-06-15 Theratech, Inc. Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
JP4708570B2 (en) * 1999-03-25 2011-06-22 スリーエム イノベイティブ プロパティズ カンパニー Non-irritating coating composition
US6471985B2 (en) * 1999-06-04 2002-10-29 Bahman Guyuron Use of RTV silicone compositions for wound dressing
GB0003632D0 (en) * 2000-02-16 2000-04-05 Univ Hong Kong Science & Techn Dimeric compounds
US6512072B1 (en) 2000-06-12 2003-01-28 Dow Corning Corporation Fast cure film forming formulation
US6902734B2 (en) 2000-08-07 2005-06-07 Centocor, Inc. Anti-IL-12 antibodies and compositions thereof
UA81743C2 (en) 2000-08-07 2008-02-11 Центокор, Инк. HUMAN MONOCLONAL ANTIBODY WHICH SPECIFICALLY BINDS TUMOR NECROSIS FACTOR ALFA (TNFα), PHARMACEUTICAL MIXTURE CONTAINING THEREOF, AND METHOD FOR TREATING ARTHRITIS
US6942875B2 (en) * 2001-07-05 2005-09-13 Closure Medical Corporation Adhesive treatment for skin yeast infections
US6746667B2 (en) 2001-07-05 2004-06-08 Closure Medical Corporation Adhesive treatment for tinea pedis
US6585967B2 (en) 2001-07-05 2003-07-01 Closure Medical Corporation Adhesive treatment for tinea cruris
US6602496B2 (en) 2001-07-05 2003-08-05 Closure Medical Corporation Adhesive treatment for tinea corporis
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ES2350689T3 (en) 2002-12-13 2011-01-26 Durect Corporation ORAL DRUG SUPPLY SYSTEM THAT INCLUDES HIGH VISCOSITY LIQUID VEHICLE MATERIALS.
US20040122382A1 (en) * 2002-12-23 2004-06-24 Kimberly-Clark Worldwide, Inc. Elastomeric articles with beneficial coating on a surface
US9708410B2 (en) 2003-05-30 2017-07-18 Janssen Biotech, Inc. Anti-tissue factor antibodies and compositions
US20050031817A1 (en) * 2003-08-07 2005-02-10 Littleton Kermit R. Readily donned, powder-free elastomeric article
US20050129937A1 (en) * 2003-12-16 2005-06-16 Eastman Kodak Company Antimicrobial web for application to a surface
US7842749B2 (en) * 2004-08-02 2010-11-30 Poly-Med, Inc. Tissue protecting spray-on copolymeric film composition
US20060030808A1 (en) * 2004-08-09 2006-02-09 Aso Corporation Liquid bandage and tissue sealant
KR101492361B1 (en) 2004-09-17 2015-02-11 듀렉트 코퍼레이션 Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
CN101084275B (en) 2004-12-23 2011-09-14 陶氏康宁公司 Crosslinkable saccharide-siloxane compositions, and networks, coatings and articles formed therefrom
JP4704764B2 (en) * 2005-02-03 2011-06-22 日東電工株式会社 Nail adhesive composition and nail patch
US7318937B2 (en) * 2005-03-18 2008-01-15 Closure Medical Corporation Liquid coating compositions
EP1885331A2 (en) 2005-05-23 2008-02-13 Dow Corning Corporation Personal care compositions comprising saccharide-siloxane copolymers
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
AU2006279369B2 (en) 2005-08-17 2011-09-08 Rochal Partners, Llp Conformable solvent-based bandage and coating material
EP1968655B1 (en) * 2005-12-07 2011-03-02 Rochal Industries, LLP Conformable bandage and coating material
US8968773B2 (en) 2006-05-23 2015-03-03 Dow Corning Corporation Silicone film former for delivery of actives
BRPI0808660A2 (en) * 2007-03-08 2014-08-19 Crescendo Thetapeutics Llc CURATIVE FORMULATIONS TO PREVENT AND REDUCE SCAR TRAINING
WO2008133868A1 (en) * 2007-04-23 2008-11-06 Safe N' Simple Stoma wipe and adhesive remover and method
US20080302827A1 (en) * 2007-06-06 2008-12-11 Gerrish Donald L Spray dispenser
JP2011506318A (en) 2007-12-06 2011-03-03 デュレクト コーポレーション Oral pharmaceutical formulation
US8828358B2 (en) * 2008-03-11 2014-09-09 Materials Modifications, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
US8852558B2 (en) * 2008-03-11 2014-10-07 Materials Modification, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
EP2303318A2 (en) 2008-06-20 2011-04-06 Wyeth LLC Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains
US8003132B2 (en) 2008-06-30 2011-08-23 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an ultraviolet radiation-absorbing polymer
CA2733642A1 (en) 2008-08-14 2010-02-18 Cephalon Australia Pty Ltd Anti-il-12/il-23 antibodies
DE102008048338A1 (en) * 2008-09-22 2010-03-25 Beiersdorf Ag Wound care preparation with reduced skin irritation
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
DE102008060904A1 (en) * 2008-12-09 2010-06-10 Beiersdorf Ag Water-soluble active ingredients in spray plaster
WO2010129299A2 (en) 2009-04-27 2010-11-11 Avery Dennison Corporation Systems, methods and materials for delivery and debonding on demand
US8957277B2 (en) 2009-04-27 2015-02-17 Avery Dennison Corporation Disruptable adhesive layer for fluid activated debonding
US8828425B2 (en) * 2010-02-02 2014-09-09 Poly-Med, Inc. In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers
US8475774B2 (en) 2010-02-08 2013-07-02 Johnson & Johnson Consumer Companies, Inc. Sunscreen compositions comprising an ultraviolet radiation-absorbing polymer
CN103068887B (en) 2010-08-23 2015-09-09 道康宁公司 Sugared siloxanes stable in aqueous environments and the preparation and application of these sugared siloxanes
JP5754665B2 (en) * 2010-10-22 2015-07-29 アルケア株式会社 Film-forming composition for alleviating skin pain
CA2843739A1 (en) 2011-08-14 2013-02-21 Materials Modification, Inc. Method and composition for in situ formation of an artificial blockage to control blood loss
US20140235712A1 (en) 2011-09-30 2014-08-21 3M Innovative Properties Company Conformable coating and composition
US8263720B1 (en) * 2011-10-05 2012-09-11 Rochal Industries, Llp Sacrificial adhesive coatings
ES2568754T3 (en) 2011-10-31 2016-05-04 Avery Dennison Corporation Afferable adhesive layer for activated fluid disunity
EP2909270A1 (en) 2012-10-22 2015-08-26 Avery Dennison Corporation Hybrid material of crosslinked microgel particles dispersed in an adhesive
WO2014064703A1 (en) * 2012-10-28 2014-05-01 Peritech Pharma Ltd. Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
MX367301B (en) 2012-11-06 2019-08-14 Rochal Ind Llc Delivery of biologically-active agents using volatile, hydrophobic solvents.
BR112015022223B1 (en) 2013-03-10 2022-06-28 Peritech Pharma Ltd TOPICAL COMPOSITION, ITS USE, AND KIT
US20140272129A1 (en) * 2013-03-15 2014-09-18 Apple Inc. Compliant permeable glue applicator
WO2014144975A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
WO2015017044A1 (en) * 2013-07-27 2015-02-05 Colby Lawrence A Systems and methods for enhancing the visibility of medical items
US8877882B1 (en) 2013-10-04 2014-11-04 Rochal Industries Llp Non-self-adherent coating materials
CN106661107B (en) 2013-12-24 2021-12-24 杨森制药公司 anti-VISTA antibodies and fragments
US9962461B2 (en) 2014-03-10 2018-05-08 3M Innovative Properties Company Conformable coating composition
EP3240823A4 (en) * 2014-12-30 2018-08-01 Momentive Performance Materials Inc. Siloxane coordination polymers
WO2016153760A1 (en) 2015-03-23 2016-09-29 Clariant Corporation A catalyst material for the oxidation and ammoxidation of propylene and isopropylene, processes for making and using same
US11491255B2 (en) * 2015-04-06 2022-11-08 3M Innovative Properties Company Removable film forming gel compositions and methods for their application
CN107922497B (en) 2015-06-24 2022-04-12 詹森药业有限公司 anti-VISTA antibodies and fragments
EP3413910A1 (en) 2016-02-12 2018-12-19 Janssen Pharmaceutica NV Anti-vista (b7h5) antibodies
CN109071653A (en) 2016-03-29 2018-12-21 詹森生物科技公司 Psoriasis is treated with the increased anti-antibody administration of IL12 and/or -23 interval
WO2017175058A1 (en) 2016-04-07 2017-10-12 Janssen Pharmaceutica Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
JP2020500152A (en) 2016-09-30 2020-01-09 ヤンセン バイオテツク，インコーポレーテツド Safe and effective method of treating psoriasis with anti-IL23 specific antibody
WO2018071278A1 (en) * 2016-10-13 2018-04-19 3M Innovative Properties Company Removable film-forming gel compositions featuring adhesion promoters
MX2019005661A (en) 2016-11-16 2019-10-07 Janssen Biotech Inc Method of treating psoriasis with anti-il-23 specific antibody.
DE102017100443A1 (en) * 2017-01-11 2018-07-12 Madeleine Elixmann Liquid plaster, applicator and their use
MX2019008989A (en) 2017-01-30 2019-10-09 Janssen Biotech Inc Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis.
CN110418652A (en) 2017-02-07 2019-11-05 詹森生物科技公司 For treating the anti-TNF antibodies, composition and method of activity ankylosing spondylitis
TW201922780A (en) 2017-09-25 2019-06-16 美商健生生物科技公司 Safe and effective method of treating Lupus with anti-IL12/IL23 antibody
EP3762015A4 (en) 2018-03-05 2022-04-27 Janssen Biotech, Inc. Methods of treating crohn's disease with anti-il23 specific antibody
JP2021530697A (en) 2018-07-18 2021-11-11 ヤンセン バイオテツク，インコーポレーテツド Sustained response predictor after treatment with anti-IL23 specific antibody
BR112021005467A2 (en) 2018-09-24 2021-06-22 Janssen Biotech, Inc. safe and effective method to treat ulcerative colitis with anti-il12/il23 antibody
CN113395979A (en) 2018-11-20 2021-09-14 詹森生物科技公司 Safe and effective methods for treating psoriasis with anti-IL-23 specific antibodies
MA54562A (en) 2018-12-18 2021-10-27 Janssen Biotech Inc SAFE AND EFFECTIVE METHOD OF TREATING LUPUS WITH AN ANTI-IL12/IL23 ANTIBODY
AU2020208828A1 (en) 2019-01-15 2021-08-05 Janssen Biotech, Inc. Anti-TNF antibody compositions and methods for the treatment of juvenile idiopathic arthritis
EA202192038A1 (en) 2019-01-23 2021-10-05 Янссен Байотек, Инк. ANTIBODY COMPOSITIONS TO TNF FOR USE IN METHODS FOR TREATMENT OF PSORIATIC ARTHRITIS
CA3133381A1 (en) 2019-03-14 2020-09-17 Janssen Biotech, Inc. Manufacturing methods for producing anti-tnf antibody compositions
CA3133395A1 (en) 2019-03-14 2020-09-17 Janssen Biotech, Inc. Manufacturing methods for producing anti-il12/il23 antibody compositions
EA202192508A1 (en) 2019-03-14 2022-03-29 Янссен Байотек, Инк. METHODS FOR OBTAINING COMPOSITIONS OF ANTIBODIES TO TNF
EP3938391A1 (en) 2019-03-14 2022-01-19 Janssen Biotech, Inc. Methods for producing anti-tnf antibody compositions
KR20210141583A (en) 2019-03-18 2021-11-23 얀센 바이오테크 인코포레이티드 Methods of Treating Psoriasis in Children Using Anti-IL-12/IL-23 Antibodies
US11780911B2 (en) 2019-05-23 2023-10-10 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
JP2022535534A (en) 2019-06-03 2022-08-09 ヤンセン バイオテツク，インコーポレーテツド Anti-TNF Antibodies, Compositions and Methods for Treating Active Ankylosing Spondylitis
KR20220029593A (en) 2019-06-03 2022-03-08 얀센 바이오테크 인코포레이티드 Anti-TNF antibody compositions, and methods for the treatment of psoriatic arthritis
WO2021028752A1 (en) 2019-08-15 2021-02-18 Janssen Biotech, Inc. Anti-tfn antibodies for treating type i diabetes
BR112022013784A2 (en) 2020-01-13 2022-10-11 Durect Corp DISTRIBUTION SYSTEMS FOR PROLONGED RELEASE DRUGS WITH REDUCED IMPURITIES AND RELATED METHODS
CN111450310A (en) * 2020-03-03 2020-07-28 劳龙斯(上海)医药科技有限公司 Novel liquid wound dressing and preparation method thereof
CN111714692B (en) * 2020-07-07 2022-04-15 华熙生物科技股份有限公司 Skin wound surface protection composition and preparation method thereof
IL305802A (en) 2021-03-12 2023-11-01 Janssen Biotech Inc Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody
EP4305062A1 (en) 2021-03-12 2024-01-17 Janssen Biotech, Inc. Method of treating psoriatic arthritis patients with inadequate response to tnf therapy with anti-il23 specific antibody
WO2023281463A1 (en) 2021-07-09 2023-01-12 Janssen Biotech, Inc. Manufacturing methods for producing anti-tnf antibody compositions
KR20240034215A (en) 2021-07-09 2024-03-13 얀센 바이오테크 인코포레이티드 Manufacturing Methods for Producing Anti-IL12/IL23 Antibody Compositions
US20230040065A1 (en) 2021-07-09 2023-02-09 Janssen Biotech, Inc. Manufacturing Methods for Producing Anti-TNF Antibody Compositions
WO2023073615A1 (en) 2021-10-29 2023-05-04 Janssen Biotech, Inc. Methods of treating crohn's disease with anti-il23 specific antibody
US20230151087A1 (en) 2021-11-15 2023-05-18 Janssen Biotech, Inc. Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
US20230159633A1 (en) 2021-11-23 2023-05-25 Janssen Biotech, Inc. Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
WO2023187707A1 (en) 2022-03-30 2023-10-05 Janssen Biotech, Inc. Method of treating mild to moderate psoriasis with il-23 specific antibody
WO2023223265A1 (en) 2022-05-18 2023-11-23 Janssen Biotech, Inc. Method for evaluating and treating psoriatic arthritis with il23 antibody

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577516A (en) * 1969-12-02 1971-05-04 Nat Patent Dev Corp Preparation of spray on bandage
US3836647A (en) * 1970-10-22 1974-09-17 Dow Corning Wash-resistant skin preparation
CA1039189A (en) * 1973-08-31 1978-09-26 Beiersdorf Aktiengesellschaft Film-forming sprayable polymer-solution for producing a wound-dressing
JPS5528918A (en) * 1978-08-18 1980-02-29 Kuraray Co Ltd Coating material
US4303066A (en) * 1979-06-28 1981-12-01 National Patent Development Corporation Burn dressing
US4318746A (en) * 1980-01-08 1982-03-09 Ipco Corporation Highly stable gel, its use and manufacture
US4393048A (en) * 1980-02-15 1983-07-12 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for wounds
US4291025A (en) * 1980-04-11 1981-09-22 Laclede Professional Products, Inc. Agar gel topical dressing
US4569784A (en) * 1980-11-17 1986-02-11 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4650817A (en) * 1982-07-16 1987-03-17 C. R. Bard, Inc. Physiologically compatible adhesive composition
FR2589737A1 (en) * 1985-11-12 1987-05-15 Dow Corning Sa METHODS OF MANUFACTURING DRESSINGS
GB2192142B (en) * 1986-07-04 1990-11-28 Johnson & Johnson Wound dressing

Also Published As

Publication number Publication date
JP2918263B2 (en) 1999-07-12
HK1007690A1 (en) 1999-04-23
EP0438496A1 (en) 1991-07-31
DE68923456D1 (en) 1995-08-17
WO1990003809A1 (en) 1990-04-19
AU4423789A (en) 1990-05-01
DE68923456T2 (en) 1995-12-14
EP0438496B1 (en) 1995-07-12
CA2000548C (en) 2000-12-05
US4987893A (en) 1991-01-29
JPH04501076A (en) 1992-02-27
EP0438496A4 (en) 1991-10-09
AU620653B2 (en) 1992-02-20

Similar Documents

Publication Publication Date Title
CA2000548A1 (en) Conformable bandage and coating material
GB2194446B (en) Wound dressing, its preparation and use
US5103812A (en) Conformable bandage and coating material
US5762955A (en) Method for application and maintenance of medication on body tissue
DE59209658D1 (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF Wounds, SCARS AND KELOIDS
IE870722L (en) Wound dressing
CA2170838A1 (en) Structured occlusive dressings
CA1306195C (en) Extended occlusive treatment of skin disorder
DE69634430D1 (en) FORMULATION FOR WOUND HEALING WITH HUMAN PLASMA FIBRONECTIN
Sawada et al. A silicone gel sheet dressing containing an antimicrobial agent for split thickness donor site wounds
Williams 3M Cavilon No Sting Barrier Film in the protection of vulnerable skin
US20010051179A1 (en) Method for preventing the spread of infectious microorganisms using cyanoacrylate
AU8411391A (en) Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery
RU2108114C1 (en) Biological composition to treat wounds
CA2075082A1 (en) Prolonged occlusion treatment system
Raab A new hydrophilic copolymer membrane for dermabrasion
DE68905076D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN Wounds.
Nangia et al. Laboratory evaluation of a new hydrogel-type skin substitute
ATE220548T1 (en) USE OF OXAZOLIDINONES FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR TRANSDERMAL ADMINISTRATION
Kaufman et al. Treatment of chronic leg ulcers with Op-Site
Williams Hydrocoll: a ‘new breed’of hydrocolloid wound dressing
RU2115436C1 (en) Agent for wound treatment
FR2392674A1 (en) Pharmaceutical compsns. contg. elastin - used for the treatment of dermal wounds, burns, sores, etc.
Buehler et al. The" Sulfamylon Sandwich"—A Laminated Mafenide-Saline Dressing
Lawrence et al. An adherent semipermeable film dressing for burns

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry